EN
DE
PL
FR
MENU
X
⤺
About Us
Meet the Team
Our Mission
Our Values
Our Customers
Services
Clinical Development
Clinical Operations
Biostatistics and Data Management
Regulatory
Pharmacovigilance
Clinical Quality
Temporary Resourcing Solutions
Real-World Evidence
Market Access
Outsourcing of Personnel
Outsourcing of Equipment
Therapeutic Area Expertise
Oncology & Haematology
Orthopaedics & Wound Healing
Central Nervous System (CNS)
Women’s & Male Health
Immunology and Cancer Immunotherapy
Respiratory Medicine
Cardiovascular
Dermatology
Metabolic & Endocrinology
Biosimilars
Rare & Orphan Disease
Gastroenterology
Ophthalmology
Infectious Diseases
Newsroom
Announcements
Blog
Articles
Join Us
Contact
RFP
Newsroom
All
Announcements
Blog
Articles
blog
From study protocol to Clinical Study Report in Covid-19 environment
A step ahead in clinical trials even during Covid-19.
READ MORE
announcements
A positive decision for BIOOPA study
At the beginning of October the Polish Competent Authority, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products gave permission for conducting the BIOOPA clinical.
READ MORE
articles
What are the new possibilities to help patients with melanoma?
Melanoma is one of the most dangerous oncological diseases and although it accounts for only 4% of all dermatologic cancers, it is responsible for 80% of deaths from skin cancer. Study results have shown that only 14% of patients with metastatic melanoma survive for five years or more.
READ MORE
announcements
Clinscience joins forces with Experior to underpin the strong position on the European clinical trials market
Following investments in Germany and Ukraine, the NEUCA Capital Group, through its subsidiary Clinscience, increases its CRO coverage by one of the largest clinical trials markets in Europe - Spain. By investing in Experior (100% shares), over a dozen million patients, develop competences in biostatistics, and expand this business area with new technological solutions.
READ MORE
announcements
Clinscience successful in organising the adoption of TheraSphere® across hospitals in Poland
Clinscience a global contract research organisation, today announced the successful adoption of TheraSphere by the Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice branch (Centrum Onkologii - Instytut, im. Marii Skłodowskiej-Curie Gliwice), Poland.
READ MORE
articles
What are the new possibilities to help patients with MDD?
Major depressive disorder (MDD) in adolescents is a commonly occurring seriously impairing and often undertreated disorder.
READ MORE
1
2
3
4
5
6
7
About Us
Meet the Team
Our Mission
Our Values
Our Customers
Services
Clinical Development
Clinical Operations
Biostatistics and Data Management
Regulatory
Pharmacovigilance
Clinical Quality
Temporary Resourcing Solutions
Real-World Evidence
Market Access
Outsourcing of Personnel
Outsourcing of Equipment
Therapeutic Area Expertise
Oncology & Haematology
Orthopaedics & Wound Healing
Central Nervous System (CNS)
Women’s & Male Health
Immunology and Cancer Immunotherapy
Respiratory Medicine
Cardiovascular
Dermatology
Metabolic & Endocrinology
Biosimilars
Rare & Orphan Disease
Gastroenterology
Ophthalmology
Infectious Diseases
Newsroom
Announcements
Blog
Articles
Join Us
Contact
Request for proposal
Request for information